Executive Profile

Dale J. Boden II, BA Co-founder and Chairman, Advanced Cancer Therapeutics, LLC

Age	Total Calculated Compensation	This person is connected to 3 Board Members in 3 different organizations across 4 different industries. See Board Relationships
55	--

Background

Mr. Dale J. Boden, II, BA is the General Partner of Yearling Management LLC. Mr. Boden serves as the President of BF Capital Inc., a private investment firm that focuses on private equity, venture capital investing and real estate development. Mr. Boden serves as a Managing Partner of the Yearling Fund, an early-stage venture capital fund. He has been Director of Bradmer Pharmaceuticals Inc. since February 2008. Mr. Boden served as a Director of Antisoma plc since September ... 13, 2005 until October 22, 2012. He served as a Director of Aptamera Inc., an oncology drug development company acquired by London-based Antisoma plc in 2005. Mr. Boden has approximately 25 years of experience in corporate finance.

Corporate Headquarters 429 West Muhammad Ali Boulevard Louisville, Kentucky 40202 United States Phone: 502-589-6404 Fax: 502-589-6391 Board Members Memberships Director University of Louisville Hospital Co-founder and Chairman Advanced Cancer Therapeutics, LLC 1994-N/A Director, Member of Compensation Committee and Director of Avondale Mills Inc Avondale Inc. 1994-N/A Former Director and Director of Avondale Incorporated Avondale Mills, Inc. 2005-2012 Former Non-Executive Director, Chairman of Remuneration Committee, Member of Audit Committee and Member of Nominations Committee Antisoma plc 2006-Present Director and Member of Audit Committee Bradmer Pharmaceuticals Inc. Education There is no Education data available. Other Affiliations Antisoma plc Avondale Inc. Avondale Mills, Inc. BF Capital University of Louisville Hospital Bradmer Pharmaceuticals Inc. Yearling Management LLC

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.